D-0053-2015 Class III Terminated
FDA drug recall D-0053-2015 was initiated by Valeant Pharmaceuticals North America LLC on Jun 5, 2014 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert The recall status is terminated (terminated Jul 27, 2017). Affected quantity: 55,650 HDPE bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 5, 2014
- Initiation Date
- Jun 5, 2014
- Termination Date
- Jul 27, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 55,650 HDPE bottles
Product description
APLENZIN¿ (bupropion hydrobromide), extended-release tablets, 522 mg, a) 7-count HDPE bottle (NDC 0024-5812-07), b) 30-count HDPE bottle (NDC 0024-5812-30), Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7
Reason for recall
Labeling: Incorrect or Missing Package Insert
Distribution pattern
Nationwide
Code information
Lot #: a) 13E023P; Exp. 03/16 Lot #: b) 12J063P; Exp. 07/15 12K063P; Exp. 09/15 12K060P; Exp. 07/15 12M073P; Exp. 09/15 13A036P; Exp. 11/15 13B035P; Exp. 11/15 13C046P; Exp. 11/15 13D060P; Exp. 11/15 13E030P; Exp. 03/16 13E031P; Exp. 03/16 13F003P; Exp. 03/16 13K034P; Exp. 03/16 14A001P; Exp. 10/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0053-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026